Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 11/14/2018 |
Start Date: | April 13, 2017 |
End Date: | June 2019 |
Contact: | Donna Shelley, MD |
Email: | shelld01@nyumc.org |
Phone: | 646 501 2526 |
This study will develop a clinical decision support tool that assists primary care providers
in carrying out substance use interventions, and then compare (in Phase 2) two clinical
scenarios, screening only (SO) vs. SUSIT, (on dose of substance use brief intervention
received) and changes in drug use at 3 and 6 months, among primary care patients.
Investigators will develop the Clinical Decision Support (CDS) component and then test the
full SUSIT approach, using mixed methods to assess its acceptability and adoption, and
gathering preliminary data on its efficacy for reducing unhealthy drug use. CDS development
is concurrent with the SO phase to avoid losing valuable time, but will be conducted at a
secondary study site to avoid contaminating the SO condition.
in carrying out substance use interventions, and then compare (in Phase 2) two clinical
scenarios, screening only (SO) vs. SUSIT, (on dose of substance use brief intervention
received) and changes in drug use at 3 and 6 months, among primary care patients.
Investigators will develop the Clinical Decision Support (CDS) component and then test the
full SUSIT approach, using mixed methods to assess its acceptability and adoption, and
gathering preliminary data on its efficacy for reducing unhealthy drug use. CDS development
is concurrent with the SO phase to avoid losing valuable time, but will be conducted at a
secondary study site to avoid contaminating the SO condition.
This study has 3 specific aims:
Aim 1 is to develop clinical decision support that assists primary care providers in carrying
out a brief intervention.
Aim 2 is to assess the impact of the SUSIT on dose of substance use brief intervention
received by patients.
Aim 3 is to gather preliminary evidence on the efficacy of the SUSIT approach for reducing
moderate-risk drug use.
Aim 1 is to develop clinical decision support that assists primary care providers in carrying
out a brief intervention.
Aim 2 is to assess the impact of the SUSIT on dose of substance use brief intervention
received by patients.
Aim 3 is to gather preliminary evidence on the efficacy of the SUSIT approach for reducing
moderate-risk drug use.
Inclusion Criteria:
- Substance use screening results (collected using the tablet-based screening tool)
indicating current moderate risk drug use, based on a substance specific involvement
score (SSIS) indicating current (past 3 months) use of at least one drug with a
moderate risk level (SSIS 4-26), in the absence of any high-risk drug or alcohol use
(SSIS 27+);
- Presenting for visit with a participating PCP
Exclusion Criteria:
- Prior participation in the study (i.e. participation in the SO study phase would
preclude participation in the SUSIT phase);
- Attending a formal addiction treatment program (not including informal treatment such
as Alcoholics Anonymous, Narcotics Anonymous), in the past 3 months;
- Pregnant (based on self-report).
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Jennifer McNeely, MD
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials